GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (XSWX:MOVE) » Definitions » EV-to-EBITDA

Medacta Group (XSWX:MOVE) EV-to-EBITDA : 21.05 (As of May. 12, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medacta Group's enterprise value is CHF2,496.5 Mil. Medacta Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF118.6 Mil. Therefore, Medacta Group's EV-to-EBITDA for today is 21.05.

The historical rank and industry rank for Medacta Group's EV-to-EBITDA or its related term are showing as below:

XSWX:MOVE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 15.93   Med: 23.16   Max: 38.8
Current: 21.06

During the past 9 years, the highest EV-to-EBITDA of Medacta Group was 38.80. The lowest was 15.93. And the median was 23.16.

XSWX:MOVE's EV-to-EBITDA is ranked worse than
62.73% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 16.47 vs XSWX:MOVE: 21.06

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-12), Medacta Group's stock price is CHF116.40. Medacta Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.282. Therefore, Medacta Group's PE Ratio for today is 51.01.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Medacta Group EV-to-EBITDA Historical Data

The historical data trend for Medacta Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group EV-to-EBITDA Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only 28.61 21.54 28.71 20.30 23.01

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.71 - 20.30 - 23.01

Competitive Comparison of Medacta Group's EV-to-EBITDA

For the Medical Devices subindustry, Medacta Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medacta Group's EV-to-EBITDA falls into.



Medacta Group EV-to-EBITDA Calculation

Medacta Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2496.514/118.589
=21.05

Medacta Group's current Enterprise Value is CHF2,496.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medacta Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF118.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medacta Group  (XSWX:MOVE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medacta Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=116.40/2.282
=51.01

Medacta Group's share price for today is CHF116.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medacta Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.282.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Medacta Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medacta Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Medacta Group (XSWX:MOVE) Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.